Remus Pharmaceuticals Ltd
REMUSRemus Pharmaceuticals Ltd
REMUS![](https://assets.tickertape.in/sector-icons/health_care.png)
![](https://assets.tickertape.in/sector-icons/smallcap.png)
![](https://assets.tickertape.in/sector-icons/high_risk.png)
Price Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
— | 80.28 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
49.93 | 6.39 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Remus Pharmaceuticals Limited is an India-based company that is engaged in the marketing and distribution of finished formulations of pharmaceutical drugs. It also deals in active pharmaceutical ingredients (API). The Company also provides technical consulting services to various distributors for the preparation of reports on the dossiers of the products. It deals in drug forms like capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension, and tablet. The Company’s business verticals include the sale of finished formulations, the sale of APIs, and technical consulting. Its product portfolio comprises a range of therapeutic drugs, namely ACE inhibitors, analgesics, anti-erectile dysfunction, anti-fibrinolytics, anti-histamines, beta blockers, carcinoid tumors, chronic obstructive pulmonary disease, and contrast reagents, among others.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 12.77 | 19.23 | 25.44 | 46.61 | 217.90 | — | ||||||
Raw Materials | 7.44 | 12.21 | 12.71 | 20.14 | 184.69 | — | ||||||
Power & Fuel Cost | 0.01 | 0.00 | 0.00 | 0.00 | ||||||||
Employee Cost | 2.86 | 2.95 | 3.42 | 5.47 | ||||||||
Selling & Administrative Expenses | 1.37 | 0.00 | 2.70 | 3.26 | ||||||||
Operating & Other expenses | -0.15 | 2.46 | 1.75 | 5.61 | ||||||||
EBITDA | 1.24 | 1.61 | 4.86 | 12.13 | 33.21 | — | ||||||
Depreciation/Amortization | 0.11 | 0.18 | 0.15 | 0.48 | 0.90 | — | ||||||
PBIT | 1.13 | 1.43 | 4.71 | 11.65 | 32.31 | — | ||||||
Interest & Other Items | 0.04 | 0.03 | 0.09 | 0.23 | 0.48 | — | ||||||
PBT | 1.09 | 1.40 | 4.62 | 11.42 | 31.83 | — | ||||||
Taxes & Other Items | 0.29 | 0.35 | 1.18 | 2.91 | 10.30 | — | ||||||
Net Income | 0.80 | 1.05 | 3.44 | 8.51 | 21.53 | — | ||||||
EPS | 50.00 | 65.62 | 4.26 | 5.10 | 38.00 | — | ||||||
DPS | 0.00 | 0.00 | 0.00 | 0.50 | 0.00 | — | ||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | — |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Remus Pharmaceuticals Ltd | 71.37 | 80.28 | — |
Sun Pharmaceutical Industries Ltd | 45.08 | 6.43 | 0.75% |
Cipla Ltd | 31.71 | 4.88 | 0.80% |
Torrent Pharmaceuticals Ltd | 70.18 | 16.95 | 0.82% |
Price Comparison
Compare REMUS with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Decreased Total Retail Holding
In last 3 months, retail holding in the company has decreased by 5.07%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
May 2023
Sep 2023
Mar 2024
Jun 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateMay 2, 2024
Dividend/Share
₹4.00
Ex DateEx Date
May 2, 2024
Cash Dividend
Ex DateEx DateOct 27, 2023
Dividend/Share
₹2.00
Ex DateEx Date
Oct 27, 2023
Cash Dividend
Ex DateEx DateSep 15, 2023
Dividend/Share
₹2.00
Ex DateEx Date
Sep 15, 2023
Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant